<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>蒲公英 | wechat-feeds</title><link>http://MjM5NDU0Mjk0Mw.favicon.privacyhide.com/favicon.ico</link><description>深耕于制药行业，与60万+制药人共同成长。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 15 Apr 2021 19:20:09 +0800</pubDate><image><url>http://MjM5NDU0Mjk0Mw.favicon.privacyhide.com/favicon.ico</url><title>蒲公英 | wechat-feeds</title><link>http://MjM5NDU0Mjk0Mw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>官宣！网售处方药解禁，全面放开</title><link>https://mp.weixin.qq.com/s/-72GB60rmyhIC8JuPSgtUQ</link><description></description><content:encoded><![CDATA[官宣！网售处方药解禁，全面放开]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>生物安全法今天实施，影响所有制药人</title><link>https://mp.weixin.qq.com/s/MlwOIxkS_e6sP1HnI1LFJw</link><description></description><content:encoded><![CDATA[生物安全法今天实施，影响所有制药人]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>用于产生真实世界证据的真实世界数据指导原则（试行）发布</title><link>https://mp.weixin.qq.com/s/ahIZ4kFZn8AUw4hsvpseAw</link><description></description><content:encoded><![CDATA[用于产生真实世界证据的真实世界数据指导原则（试行）发布]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>安徽、辽宁两省：明确中药配方颗粒标准制订要求</title><link>https://mp.weixin.qq.com/s/7o7448BhhqIoMz-Ulr7LBQ</link><description></description><content:encoded><![CDATA[安徽、辽宁两省：明确中药配方颗粒标准制订要求]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>“2345”，药品流通环节监管这么干</title><link>https://mp.weixin.qq.com/s/8JeyvjRrhbThP6Bbzn8PBg</link><description></description><content:encoded><![CDATA[“2345”，药品流通环节监管这么干]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>国知局宣告舒尼替尼晶型专利无效，石药、豪森、科伦获批上市！</title><link>https://mp.weixin.qq.com/s/1nNkG2YynSJlp8ujyBseEQ</link><description></description><content:encoded><![CDATA[国知局宣告舒尼替尼晶型专利无效，石药、豪森、科伦获批上市！]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>制药用水和清洁验证中的TOC检测：实验室、旁线和在线分析比较</title><link>https://mp.weixin.qq.com/s/29y5aIewsXz4qer2esMqlg</link><description></description><content:encoded><![CDATA[制药用水和清洁验证中的TOC检测：实验室、旁线和在线分析比较]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>2021药品注册（中美双报）实战技能辅导与现场实操演练高级研修班</title><link>https://mp.weixin.qq.com/s/gjlW_flUebkIahBW3GqFcw</link><description></description><content:encoded><![CDATA[2021药品注册（中美双报）实战技能辅导与现场实操演练高级研修班]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:15:05 +0800</pubDate></item><item><title>出现6例脑血栓，1例死亡，FDA：暂停使用强生疫苗</title><link>https://mp.weixin.qq.com/s/baNVLEDCWJHbHyRP4nOo9g</link><description></description><content:encoded><![CDATA[出现6例脑血栓，1例死亡，FDA：暂停使用强生疫苗]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>16家药企被责令整改</title><link>https://mp.weixin.qq.com/s/LMotZP855F57bj2bunR-vg</link><description></description><content:encoded><![CDATA[16家药企被责令整改]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>5家药企宣告药物研发失败！</title><link>https://mp.weixin.qq.com/s/BV6ycjyZt39RrXKEi1AicQ</link><description></description><content:encoded><![CDATA[5家药企宣告药物研发失败！]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>乐纯生物临港厂区正式运营！</title><link>https://mp.weixin.qq.com/s/gHzpo-kzigC5C0gTeAhjyQ</link><description></description><content:encoded><![CDATA[乐纯生物临港厂区正式运营！]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>首例“严重”失信药品招采出现，因商业贿赂被暂停销售</title><link>https://mp.weixin.qq.com/s/9SV6wRmJPUrO6qqcHvIq3w</link><description></description><content:encoded><![CDATA[首例“严重”失信药品招采出现，因商业贿赂被暂停销售]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>四次下调挂牌价后 莎普爱思终甩亏损包袱</title><link>https://mp.weixin.qq.com/s/PwV_A0AsXBptGevqQUzM2A</link><description></description><content:encoded><![CDATA[四次下调挂牌价后 莎普爱思终甩亏损包袱]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>NMPA：桂附地黄颗粒转换为非处方药，修订曲马多栓剂和复方制剂药品说明书</title><link>https://mp.weixin.qq.com/s/WaFnBXwsXqXwCJqZJ0ocCw</link><description></description><content:encoded><![CDATA[NMPA：桂附地黄颗粒转换为非处方药，修订曲马多栓剂和复方制剂药品说明书]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>5月9日第六届PET(制药工程技术)峰会|青岛</title><link>https://mp.weixin.qq.com/s/iLi8hGMT2JFEmkY3IjNh_w</link><description></description><content:encoded><![CDATA[5月9日第六届PET(制药工程技术)峰会|青岛]]></content:encoded><pubDate>Wed, 14 Apr 2021 19:01:24 +0800</pubDate></item><item><title>解决中药农残，新办法来了！</title><link>https://mp.weixin.qq.com/s/kmFi6HJgJzsaCql0aiCEwg</link><description></description><content:encoded><![CDATA[解决中药农残，新办法来了！]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:18:03 +0800</pubDate></item><item><title>康弘回应暂停康柏西普PANDA试验：国内认可，但“出海”依然困难重重</title><link>https://mp.weixin.qq.com/s/miDK2ddEWHvc4iYfv-0eBw</link><description></description><content:encoded><![CDATA[康弘回应暂停康柏西普PANDA试验：国内认可，但“出海”依然困难重重]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:18:03 +0800</pubDate></item><item><title>CDE:公开征求17个品种指导原则意见</title><link>https://mp.weixin.qq.com/s/YvQC5KjLgDgmT--M9l74tw</link><description></description><content:encoded><![CDATA[CDE:公开征求17个品种指导原则意见]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:18:03 +0800</pubDate></item><item><title>《中药注射剂超滤工艺技术规范》等4项团体标准项目立项</title><link>https://mp.weixin.qq.com/s/ufFWXZm0JfapuRZkThXj1A</link><description></description><content:encoded><![CDATA[《中药注射剂超滤工艺技术规范》等4项团体标准项目立项]]></content:encoded><pubDate>Tue, 13 Apr 2021 19:18:03 +0800</pubDate></item></channel></rss>